Supplement: Schizophrenia in Childhood

1 This diagnosis is often difficult to confirm, because it is quite common for children to have magical thinking or beliefs, and they often report auditory hallucinations that occur upon waking or sleeping (hypnagogia or hypnopompia, respectively). In addition, children may not be able to articulate their psychotic symptoms as clearly as adolescents or adults, thus making the diagnosis less clear-cut. So, too, can other symptoms mistakenly resemble psychosis, including idiosyncratic thi

Written byGholson J. Lyon and Harold S. Koplewicz
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

So, too, can other symptoms mistakenly resemble psychosis, including idiosyncratic thinking and perceptions associated with pervasive developmental disorder (PDD), psychotic-like symptoms arising in children with posttraumatic stress syndrome, or anxiety-related transient "phobic" hallucinations. The symptoms of psychosis in childhood differ qualitatively and quantitatively from the adult form, and these symptoms must be interpreted in relationship to the developmental age. Once you identify psychotic or quasi-psychotic symptoms in children, you look for the cause, which includes a number of disorders: autism, disintegrative disorder, affective psychoses, Asperger's syndrome, drug-induced psychosis and psychotic states caused by organic disorders, and, rarely, childhood-onset schizophrenia.

Occurring in fewer than 1 in 10,000 children, childhood-onset schizophrenia (COS) is characterized by the onset of psychosis before the age of 13 years. Most people show signs of the disease later in life: There is a dramatic increase in the frequency of schizophrenia between 13 and 18 years of age ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies